Brain-specific modulation of kynurenic acid synthesis in the rat

Journal of Neurochemistry

Volumn 69, Issue 1, 1997, Pages 290-298

  Gramsbergen, Jan Bert P ^a,c   Hodgkins, Paul S ^a   Rassoulpour, Arash ^a   Turski, Waldemar A ^a,d   Guidetti, Paolo ^a   Schwarcz, Robert ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d Medical School   (Poland)

Author keywords

Energy metabolism; Excitotoxicity; Glia; Kynurenines; Neuroprotection; Quisqualate

Indexed keywords

2 AMINOADIPIC ACID; AMINO ACID RECEPTOR BLOCKING AGENT; KYNURENIC ACID; QUISQUALIC ACID; VERATRIDINE;

ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; BRAIN SLICE; CONTROLLED STUDY; ENERGY METABOLISM; GLIA; KIDNEY; LIVER; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0030957197     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69010290.x     Document Type: Article

References (49)

1. Badar-Goffer R. S., Ben-Yoseph O., Bachelard H. S., and Morris P.O. (1992) Neuronal-glial metabolism under depolarizing conditions. Biochem. J. 282, 225-230.
2. Ceresoli G., Guidetti P., and Schwarcz R. (1996) Kynurenic acid production in the rat striatum: acute and chronic effects of quinolinate lesions. Soc. Neurosci. Abstr. 22, 1543.
3. Christensen H. N. (1984) Organic ion transport during seven decades: the amino acids. Biochim. Biophys. Acta 779, 255-269.
4. Clark J. B., Bates T. E., Cullingford T., and Land J. M. (1993) Development of energy metabolism in the neonatal mammalian brain. Dev. Neurosci. 15, 174-180.
5. Du F., Schmidt W., Okuno E., Kido R., Köhler C., and Schwarcz R. (1992) Localization of kynurenine aminotransferase immunoreactivity in the rat hippocampus. J. Comp. Neurol. 321, 477-487.
6. Duffy S. and MacVicar B. A. (1993) Voltage-dependent toxic channels in astrocytes, in Astrocytes, Pharmacology and Function (Murray S., ed), pp. 137-169. Academic Press, San Diego.
7. Eaton D. C., Becchetti A., Ma H., and Ling B. N. (1995) Renal sodium channels: regulation and single channel properties. Kidney Int. 48, 941-949.
8. Edmond J., Robbins R. A., Bergstrom J. D., Cole R. A., and de Vellis J. (1987) Capacity for substrate utilization in oxidative metabolism by neurons, astrocytes and oligodendrocytes from developing brains in primary culture. J. Neurosci. Res. 18, 551-561.
9. Ellinger A. (1904) Die Entstehung der Kynurensäure. Z. Physiol. Chem. 43, 325-337.
10. Foster A.C., Vezzani A., French E. D., and Schwarcz R. (1984) Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid. Neurosci. Lett. 48, 273-278.
11. Fujikawa D. J., Kim J. S., Daniels A. H., Alcaraz A. F., and Sohn T. B. (1996) In vivo elevation of extracellular potassium in the rat amygdala increases extracellular glutamate and aspartate and damages neurons. Neuroscience 74, 695-706.
12. Ganong A. H., Lanthorn T. H., and Cotman C. W. (1983) Kynurenic acid inhibits synaptic and acidic amino acid-induced responses in the rat hippocampus and spinal cord. Brain Res. 273, 170-174.
13. Germano I. M., Pitts L. H., Meldrum B. S., Bartkowski H. M., and Simon R. P. (1987) Kynurenate inhibition of cell excitation decreases stroke size and deficits. Ann. Neurol. 22, 730-734.
14. Giebisch G. (1995) Renal potassium channels: an overview. Kidney Int. 48, 1004-1009.
15. Joseph M. H., Baker H. F., and Lawson A. M. (1978) Positive identification of kynurenine in rat and human brain. Biochem. Soc. Trans. 6, 123-126.
16. Kessler M., Terramani T., Lynch G., and Baudry M. (1989) A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists. J. Neurochem. 52, 1319-1328.
17. 18FDG and computed tomographic scan. Ann. Neurol. 12, 425-434.
18. Leeson P.D. and Iversen L. L. (1994) The glycine site on the NMDA receptor-activity relationships and therapeutic potential. J. Med. Chem. 37, 4053-4067.
19. Lowry O. H., Rosebrough N. J., Fair A. L., and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
20. Magistretti P. J., Sorg O., and Martin S. L. (1993) Regulation of glycogen metabolism in astrocytes: physiological, pharmacological and pathological aspects, in Astrocytes: Pharmacology and Function (Murray S., ed), pp. 243-265. Academic Press, San Diego.
21. Malgouris C., Daniel M., and Doble A. (1994) Neuroprotective effects of riluzole on N-methyl-D-aspartate-or veratridine-induced neurotoxicity in rat hippocampal slices. Neurosci. Lett. 177, 95-99.
22. Mason M. (1954) The kynurenine transaminase of rat kidney. J. Biol. Chem. 211, 839-844.
23. Moroni F., Russi P., Lombardi G., Beni M., and Carla V. (1988) Presence of kynurenic acid in the mammalian brain. J. Neurochem. 51, 177-180.
24. Okuno E., Schmidt W., Parks D. A., Nakamura M., and Schwarcz R. (1991) Measurement of rat brain kynurenine aminotransferase at physiological kynurenine concentrations. J. Neurochem. 57, 533-540.
25. Perkins M. N. and Stone T. W. (1982) An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Res. 247, 184-187.
26. Pin J.-P. and Duvoisin R. (1995) The metabotropic glutamate receptors: structure and functions. Neuropharmacology 34, 1-26.
27. Reeves W. B. and Andreoli T. E. (1992) Renal epithelial chloride channels. Annu. Rev. Physiol. 54, 29-50.
28. 3H] kynurenine as a substrate. Neuroscience 55, 177-184.
29. Schwarcz R. (1992) Excitotoxins, kynurenines and neuropsychiatrie diseases: implications for drug development, in Drug Research Related to Neuroactive Amino Acids (Schousboe A., Diemer N. H., and Kofod H., eds), pp. 287-301. Munksgaard, Copenhagen.
30. Schwarcz R., Whetsell W. O. Jr., and Mangano R. M. (1983) Quinolinic acid: an endogenous metabolite that causes axon-sparing lesions in rat brain. Science 219, 316-318.
31. Schwarcz R., Guidetti P., and Roberts R. C. (1996) Quinolinic acid and kynurenic acid: glia-derived modulators of excitotoxic brain injury, in The Role of Glia in Neurotoxicity (Aschner M. and Kimelberg H. K., eds), pp. 245-262. CRC Press, Boca Raton, Florida.
32. Sontheimer H. (1994) Voltage-dependent ion channels in glial cells. Glia 11, 156-172.
33. Speciale C., Wu H.-Q., Gramsbergen J. B. P., Turski W. A., Ungerstedt U., and Schwarcz R. (1990) Determination of extracellular kynurenic acid in the striatum of unanesthetized rats: effect of aminooxyacetic acid. Neurosci. Lett. 116, 198-203.
34. Speciale C., Wu H.-Q., Cini M., Marconi M., Varasi M., and Schwarcz R. (1996) (R,S)-3,4-Dichlorobenzoylalanine (FCE 28833A) causes a large and persistent increase in brain kynurenic acid levels in rats. Eur. J. Pharmacol. 315, 263-267.
35. Steinhäuser C. and Gallo V. (1996) News on glutamate receptors in glial cells. Trends Neurosci. 19, 339-345.
36. Stone T. W. (1993) Neuropharmacology of quinolinic and kynurenic acids. Pharmacol. Rev. 45, 309-379.
37. Swartz K. J., Matson W. R., MacGarvey U., Ryan E. A., and Beal M. F. (1990) Measurement of kynurenic acid in mammalian brain extracts and cerebrospinal fluid by high-performance liquid chromatography with fluorometric and coulometric electrode array detection. Anal. Biochem. 185, 363-376.
38. Takeuchi F., Otsuka H., and Shibata Y. (1983) Purification, characterization and identification of rat liver mitochondrial kynurenine aminotransferase with α-aminoadipate aminotransferase. Biochim. Biophys. Acta 743, 323-330.
39. Tsai M. J., Chang Y.-F., Schwarcz R., and Brookes N. (1996) Characterization of L-α-aminoadipic acid transport in cultured rat astrocytes. Brain Res. 741, 166-173.
40. Turski W. A., Nakamura M., Todd W. P., Carpenter B. K., Whetsell W. O. Jr., and Schwarcz R. (1988) Identification and quantification of kynurenic acid in human brain tissue. Brain Res. 454, 164-169.
41. Turski W. A., Gramsbergen J. B. P., Traitler H., and Schwarcz R. (1989) Rat brain slices produce and liberate kynurenic acid upon exposure to L-kynurenine. J. Neurochem. 52, 1629-1636.
42. + channels: a rational and effective strategy against ischemic brain damage. Pharmacol. Rev. 48, 21-67.
43. Urenjak J., Tegtmeier F., Beile A., Khan S., and Peters T. H. (1991) Synaptosomal respiration: a potent indicator of veratridine-induced Na influx. Pharmacology 439, 26-35.
44. Whittam R. (1962) The dependence of the respiration of brain cortex on active cation transport. Biochem. J. 82, 205-212.
45. Wieloch T. (1985) Hypoglycemia-induced neuronal damage prevented by an N-methyl-D-aspartate antagonist. Science 230, 681-683.
46. Williams K., Chao J., Kashiwagi K., Masuko T., and Igarashi K. (1996) Activation of N-methyl-D-aspartate receptors by glycine: role of an aspartate residue in the M3-M4 loop of the NR1 subunit. Mol. Pharmacol. 50, 701-708.
47. Wu H.-Q., Baran H., Ungerstedt U., and Schwarcz R. (1992) Kynurenic acid in the quinolinate-lesioned rat hippocampus: studies in vitro and in vivo. Eur. J. Neurosci. 4, 1264-1270.
48. Wu H.-Q., Ungerstedt U., and Schwarcz R. (1995) L-α-Aminoadipic acid as a regulator of kynurenic acid production in the hippocampus: a microdialysis study in freely moving rats. Eur. J. Pharmacol. 281, 55-61.
49. Zinkand W. C., DeFeo P. A., Thompson C., Hargrove H., Salama A. I., and Patel J. (1992) Quisqualate neurotoxicity in rat cortical cultures: pharmacology and mechanisms. Eur. J. Pharmacol. 212, 129-136.